CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Assets
Cash and due from banks	$ 431,471	$ 205,156
Interest bearing deposits with banks	686,877	1,844,764
Investment securities:
Equity securities	43,318	36,473
Trading debt securities	4,100	38,130
Available for sale debt securities	1,271,854	1,128,809
Held to maturity debt securities (net of allowance for credit losses of $1,696 at September 30, 2022 and $1,165 at December 31, 2021)	3,720,324	2,667,532
Total investment securities	5,039,596	3,870,944
Loans held for sale, at fair value	6,073	139,516
Loans	45,185,764	34,153,657
Less: Allowance for loan losses	(475,744)	(359,202)
Net loans	44,710,020	33,794,455
Premises and equipment, net	362,203	326,306
Lease right of use assets	314,511	259,117
Bank owned life insurance	714,649	566,770
Accrued interest receivable	159,406	96,882
Goodwill	1,871,505	1,459,008
Other intangible assets, net	208,226	70,386
Other assets	1,422,964	813,139
Total Assets	55,927,501	43,446,443
Deposits:
Non-interest bearing	15,420,625	11,675,748
Interest bearing:
Savings, NOW and money market	23,559,662	20,269,620
Time	6,328,556	3,687,044
Total deposits	45,308,843	35,632,412
Total short-term borrowings	919,283	655,726
Long-term borrowings	1,541,097	1,423,676
Junior subordinated debentures issued to capital trusts	56,673	56,413
Lease liabilities	367,428	283,106
Accrued expenses and other liabilities	1,460,348	311,044
Total Liabilities	49,653,672	38,362,377
Shareholders’ Equity
Common stock (no par value, authorized 650,000,000 shares; issued 507,896,910 and 423,034,027 shares at September 30, 2022 and December 31, 2021)	178,185	148,482
Surplus	4,972,732	3,883,035
Retained earnings	1,100,838	883,645
Accumulated other comprehensive loss	(165,557)	(17,932)
Treasury stock, at cost (1,545,408 common shares at September 30, 2022 and 1,596,959 common shares at December 31, 2021)	(22,060)	(22,855)
Total Shareholders’ Equity	6,273,829	5,084,066
Total Liabilities and Shareholders’ Equity	55,927,501	43,446,443
Series A
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	111,590	111,590
Series B
Shareholders’ Equity
Preferred stock, no par value; 50,000,000 authorized shares:	$ 98,101	$ 98,101